CLINICAL_TRIALS
trial_result
· 2024-05-14
Clinical Trial Update: TXA in Spinal Fusion [Phase 2]
Summary
Phase 2 clinical trial evaluating tranexamic acid in spinal fusion for degenerative disc disease has completed. Results were posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Catherine R. Olinger | Conditions: Degenerative Disc Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-05-14